Review Volume 17, Issue 5 pp 1340—1367

Age-associated changes in the heart: implications for COVID-19 therapies

Colby Wood1, , Wm. Zachary Salter1, , Isaiah Garcia1, , Michelle Nguyen1, , Andres Rios1, , Jacqui Oropeza1, , Destiny Ugwa1, , Upasana Mukherjee1, , Ujala Sehar1, , P. Hemachandra Reddy1,2,3,4,5,6, ,

  • 1 Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
  • 2 Nutritional Sciences Department, College Human Sciences, Texas Tech University, Lubbock, TX 79409, USA
  • 3 Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
  • 4 Department of Neurology, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
  • 5 Department of Public Health, Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
  • 6 Department of Speech, Language, and Hearing Sciences, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA

Received: March 3, 2025       Accepted: April 22, 2025       Published: May 13, 2025      

https://doi.org/10.18632/aging.206251
How to Cite

Copyright: © 2025 Wood et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Cardiac aging involves progressive structural, functional, cellular, and molecular changes that impair heart function. This review explores key mechanisms, including oxidative stress, mitochondrial dysfunction, impaired autophagy, and chronic low-grade inflammation. Excess reactive oxygen species (ROS) damage heart muscle cells, contributing to fibrosis and cellular aging. Mitochondrial dysfunction reduces energy production and increases oxidative stress, accelerating cardiac decline. Impaired autophagy limits the removal of damaged proteins and organelles, while inflammation activates signaling molecules that drive tissue remodeling. Gender differences reveal estrogen’s protective role in premenopausal women, with men showing greater susceptibility to heart muscle dysfunction and injury. After menopause, women lose this hormonal protection, increasing their risk of cardiovascular conditions. Ethnic disparities, particularly among underserved minority populations, emphasize how social factors such as access to care, environment, and chronic stress contribute to worsening cardiovascular outcomes. The coronavirus disease pandemic has introduced further challenges by increasing the incidence of heart damage through inflammation, blood clots, and long-term heart failure, especially in older adults with existing metabolic conditions like diabetes and high blood pressure. The virus’s interaction with receptors on heart and blood vessel cells, along with a weakened immune response in older adults, intensifies cardiac aging. Emerging therapies include delivery of therapeutic extracellular vesicles, immune cell modulation, and treatments targeting mitochondria. In addition, lifestyle strategies such as regular physical activity, nutritional improvements, and stress reduction remain vital to maintaining cardiac health. Understanding how these biological and social factors intersect is critical to developing targeted strategies that promote healthy aging of the heart.

Abbreviations

ACE2: Angiotensin I converting enzymel; CB2R: Cannabinoid 2 receptor; CDC: Center for Disease Control; COVID-19: Coronavirus disease 2019; CVD: Cardiovascular diseases; HF: Heart failure; MI: Myocardial infarction; MiRNAs: Micro RNAs; MOA: Monoamine oxidase; MSC: Mesenchymal stem cells; ROS: Reactive oxygen species; SASP: Senescence-associated secretory phenotype; SOD: Superoxide dismutase; TDEE: Total daily energy expenditure.